FCCC LOGO Faculty Publications
Westin JR , Thompson MA , Cataldo VD , Fayad LE , Fowler N , Fanale MA , Neelapu S , Samaniego F , Romaguera J , Shah J , McLaughlin P , Pro B , Kwak LW , Sanjorjo P , Murphy WA , Jimenez C , Toth B , Dong WL , Hagemeister FB
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial
Clinical Lymphoma Myeloma & Leukemia. 2013 Apr;13(2) :99-105
PMID: WOS:000319248400001   
Back to previous list
Abstract
Notes
Westin, Jason R. Thompson, Michael A. Cataldo, Vince D. Fayad, Luis E. Fowler, Nathan Fanale, Michelle A. Neelapu, Saatva Samaniego, Felipe Romaguera, Jorge Shah, Jatin McLaughlin, Peter Pro, Barbara Kwak, Larry W. Sanjorjo, Perpetua Murphy, William A. Jimenez, Camillo Toth, Bela Dong, Wenli Hagemeister, Fredrick B.